MOLECULAR BASIS OF IMMUNOGLOBULIN HEAVY CHAIN SWITCH
免疫球蛋白重链开关的分子基础
基本信息
- 批准号:3135188
- 负责人:
- 金额:$ 25.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-08-01 至 1989-07-31
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte endonuclease endoribonucleases gene complementation gene expression genetic manipulation genetic mapping hybridomas immunofluorescence technique immunogenetics immunoglobulin G immunoglobulin M immunoglobulin genes immunoglobulins immunoregulation laboratory mouse lymphoma molecular cloning molecular oncology nucleic acid sequence protein biosynthesis tissue /cell culture
项目摘要
The murine B cell lymphoma, I.29, consists of cells expressing either IgM
or IgA with the identical idiotype and with the identical heavy (H) chain
variable (V) region sequence. By DNA blotting experiments and by
examination of cloned H chain genes, we found that the IgM cells contain
one expressed VDJ-CMu gene and one non-expressed DJ-CMu gene segment, and
all the other H chain C genes in the germline configuration. The IgA cells
have deleted Mu genes from both chromosomes, and have undergone a typical
switch recombination with the Alpha gene on the expressed chromosomes, and
the Gamma3 gene on the non-expressed chromosome.
When purified IgM cells from the tumor are cultured in vitro they can be
induced to switch to IgA or to IgE with LPS or with monoclonal anti-IgM or
anti-I.29 idiotype (Id). We propose to clone T cells which will help the
switch to either IgA or to IgE. We plan to clone DNA fragments bearing the
rearranged Alpha and Mu genes about 3 days after induction of switching to
examine the earliest DNA recombination events, to determine whether
specific sites are involved and whether sister-chromatid exchange may occur.
The IgM cells appear to be committed to switch to either IgA or IgE, as the
Alphagene is hypomethylated (relative to liver DNA) in the IgM cells,
whereas the Gamma2b gene is not. Furthermore, the Alpha and Epsilon genes
are being transcribed at a low level in the IgM cells, whereas the Gamma1
and Gamma2b genes are not. We will further examine the mechanism of
predetermination of isotype specificity by studies of chromatin structure
and by attempting to induce isotype switching in hybrids of the B cell
lymphoma, WEHI 279, and I.29Mu cells. The DNA sequences required for
isotype switching and the specificity of switching will be studied by
transfection of Ig H chain gene constructs which can serve as substrates
for switch recombination into I.29Mu cells, which will then be induced to
switch. Eventually we will attempt to prepare a cell-free system which can
recombine switch region sequences. Our plans also include the cloning of
cDNAs for poly(A)+ RNAs which appear when switching is induced. We will
attempt to determine what proteins these genes encode.
小鼠B细胞淋巴瘤I.29由表达IgM的细胞组成
或具有相同独特型和相同重(H)链的IgA
可变(V)区序列。通过DNA印迹实验和
对克隆的H链基因进行检测,我们发现IgM细胞中含有
一个表达VDJ-CMU基因片段和一个未表达的DJ-CMU基因片段,以及
生殖系构型中的所有其他H链C基因。免疫球蛋白A细胞
已经从两条染色体上删除了Mu基因,并经历了典型的
与表达的染色体上的Alpha基因切换重组,以及
未表达染色体上的Gamma3基因。
当从肿瘤中纯化的IgM细胞在体外培养时,它们可以
用脂多糖或单抗诱导转成IgA或IgE
抗I.29独特型(ID)。我们建议克隆T细胞,这将有助于
切换到IgA或IgE。我们计划克隆带有该基因的DNA片段
Alpha和Mu基因重排约在诱导后3天
检查最早的DNA重组事件,以确定
是否会发生姐妹染色单体交换,以及是否涉及特定的位点。
IgM细胞似乎致力于转换为IgA或IgE,因为
Alphagene在IgM细胞中是低甲基化的(相对于肝脏DNA),
而Gamma2b基因则不是。此外,Alpha和Epsilon基因
在IgM细胞中低水平转录,而Gamma1
而Gamma2b基因则不是。我们将进一步研究其机制。
通过对染色质结构的研究预先确定同型特异性
并试图在B细胞的杂交体中诱导同型转换
淋巴瘤、WEHI 279和I.29Mu细胞。所需的DNA序列
同种类型的转换和转换的专一性将通过
可作为底物的免疫球蛋白H链基因载体的转染
用于开关重组到I.29Mu细胞,然后将被诱导
换一下。最终,我们将尝试准备一种无细胞系统,它可以
重组开关区域序列。我们的计划还包括克隆
诱导转换时出现的Poly(A)+RNA的cDNA。我们会
试图确定这些基因编码什么蛋白质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Janet M. Stavnezer其他文献
Janet M. Stavnezer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Janet M. Stavnezer', 18)}}的其他基金
Function of the AID C terminus in Ig class switching
AID C 末端在 Ig 类别转换中的功能
- 批准号:
8292343 - 财政年份:2012
- 资助金额:
$ 25.39万 - 项目类别:
Molecular Basis of Immunoglobulin Heavy Chain Switch
免疫球蛋白重链开关的分子基础
- 批准号:
8090512 - 财政年份:2010
- 资助金额:
$ 25.39万 - 项目类别:
c-myc DNA breaks and c-myc-IgH locus translocations: roles of AID and oxidation
c-myc DNA 断裂和 c-myc-IgH 基因座易位:AID 和氧化的作用
- 批准号:
7865093 - 财政年份:2010
- 资助金额:
$ 25.39万 - 项目类别:
c-myc DNA breaks and c-myc-IgH locus translocations: roles of AID and oxidation
c-myc DNA 断裂和 c-myc-IgH 基因座易位:AID 和氧化的作用
- 批准号:
8097530 - 财政年份:2010
- 资助金额:
$ 25.39万 - 项目类别:
Molecular Basis of Immunoglobulin Heavy Chain Switch
免疫球蛋白重链开关的分子基础
- 批准号:
7846563 - 财政年份:2009
- 资助金额:
$ 25.39万 - 项目类别:
Isotype specific regulation of lg class switching
LG 类别转换的同种型特异性调节
- 批准号:
7140383 - 财政年份:2005
- 资助金额:
$ 25.39万 - 项目类别:
Isotype specific regulation of lg class switching
LG 类别转换的同种型特异性调节
- 批准号:
6965565 - 财政年份:2005
- 资助金额:
$ 25.39万 - 项目类别:
相似海外基金
Preclinical evaluation of a homing endonuclease gene therapy for adRP in models of P23H retinopathy.
P23H 视网膜病变模型中 adRP 归巢核酸内切酶基因疗法的临床前评估。
- 批准号:
10587797 - 财政年份:2023
- 资助金额:
$ 25.39万 - 项目类别:
Investigating the use of a novel Dualase (dual-endonuclease) system in repairing nonsense mutations and restoring CFTR expression in cystic fibrosis mouse and human airway models
研究使用新型 Dualase(双核酸内切酶)系统修复囊性纤维化小鼠和人类气道模型中的无义突变并恢复 CFTR 表达
- 批准号:
486584 - 财政年份:2022
- 资助金额:
$ 25.39万 - 项目类别:
Studentship Programs
Elucidating Mechanisms of RAG Endonuclease Mediated Feedback Inhibition of V(D)J Recombination
阐明 RAG 核酸内切酶介导的 V(D)J 重组反馈抑制机制
- 批准号:
10538891 - 财政年份:2022
- 资助金额:
$ 25.39万 - 项目类别:
Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy
用于抗病毒治疗的布尼亚病毒核酸内切酶抑制剂的发现
- 批准号:
10481430 - 财政年份:2022
- 资助金额:
$ 25.39万 - 项目类别:
Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy
用于抗病毒治疗的布尼亚病毒核酸内切酶抑制剂的发现
- 批准号:
10683329 - 财政年份:2022
- 资助金额:
$ 25.39万 - 项目类别:
Elucidating Mechanisms of RAG Endonuclease Mediated Feedback Inhibition of V(D)J Recombination
阐明 RAG 核酸内切酶介导的 V(D)J 重组反馈抑制机制
- 批准号:
10664014 - 财政年份:2022
- 资助金额:
$ 25.39万 - 项目类别:
Repurposing Endonuclease V for the detection and engineering of adenosine-to-inosine editing
重新利用核酸内切酶 V 进行腺苷至肌苷编辑的检测和改造
- 批准号:
10729813 - 财政年份:2021
- 资助金额:
$ 25.39万 - 项目类别:
FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy
FEN1 核酸内切酶作为癌症治疗的合成致死靶点
- 批准号:
10294863 - 财政年份:2021
- 资助金额:
$ 25.39万 - 项目类别:
FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy
FEN1 核酸内切酶作为癌症治疗的合成致死靶点
- 批准号:
10467002 - 财政年份:2021
- 资助金额:
$ 25.39万 - 项目类别:
Repurposing Endonuclease V for the detection and engineering of adenosine-to-inosine editing
重新利用核酸内切酶 V 进行腺苷至肌苷编辑的检测和改造
- 批准号:
10322142 - 财政年份:2021
- 资助金额:
$ 25.39万 - 项目类别: